Maven Securities LTD Abbott Laboratories Transaction History

Maven Securities LTD

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$95.53 - $114.62 $939,059 - $1.13 Million	-9,830 Reduced 75.46%	3,197 $309,000
Q2 2023 Aug 04, 2023	BUY	$100.78 - $112.29 $1.31 Million - $1.46 Million	13,027 New	13,027 $1.42 Million
Q3 2022 Nov 14, 2022	BUY	$96.76 - $112.03 $952,021 - $1.1 Million	9,839 New	9,839 $9.52 Million
Q1 2022 May 16, 2022	SELL	$114.02 - $139.04 $260,307 - $317,428	-2,283 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$115.53 - $141.46 $263,754 - $322,953	2,283 New	2,283 $321,000
Q3 2021 Nov 15, 2021	SELL	$116.66 - $129.06 $2.4 Million - $2.65 Million	-20,554 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$105.79 - $124.53 $1.82 Million - $2.14 Million	17,165 Added 506.49%	20,554 $2.38 Million
Q1 2021 May 17, 2021	BUY	$108.84 - $128.23 $115,152 - $135,667	1,058 Added 45.39%	3,389 $409,000
Q4 2020 Feb 12, 2021	BUY	$105.0 - $114.42 $244,755 - $266,713	2,331 New	2,331 $255,000

3,189

1.3B

8.74M

8.08M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $197B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Maven Securities LTD, based on Form 13F filings with the SEC.

Stay updated on Maven Securities LTD with notifications on news.